In October, a woman in Phoenix named Karen ran an experiment on her own face without meaning to.
She had been on transdermal estradiol for three years. She changed the patch every Sunday and Wednesday like clockwork. The pharmacy called her on a Thursday and said the manufacturer had a delay. She would not be able to refill her prescription for at least two weeks. Two weeks became five.
The first ten days she noticed her skin was thirsty in a way it had not been in two years. By week three the texture of her cheeks had changed. By the end of week four she was emailing photos to herself with subject lines like "is this worse than yesterday" so she could remember the order.
When the patches finally came back in, Karen expected to bounce all the way back. She did not.
Within ten days her skin was hydrated again. Within three weeks the dryness was gone. The thirsty look went away. But the structural changes that had drifted further during the gap, the softer fold under her eyes, the drift along her jawline, the subtle slumping where her cheeks used to sit, those did not return when the estrogen did. Karen estimated she got about 70 percent of her face back.
The other 30 percent stayed gone.
I started reporting this story because Karen is not unusual. I have been collecting accounts from women who experienced unintended gaps in their HRT protocols, the 2022 estradiol shortage, the 2024 heat wave that wouldn't let transdermal patches stay on through the summer, a forgotten suitcase, an unexpected pharmacy closure. Across those interviews, the same pattern: hydration came back, structure did not. The number women kept landing on, when I asked them to estimate, was somewhere between 65 and 75 percent.
Something about the gap was not reversible. That was the question I went looking to answer.